Agachan F (1996)
Agachan F, Chen T, Pfeifer J, Reissman P, Wexner SD. A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum. 1996;39(6):681-5.

Agra Y (1998)
Agra Y, Sacristan A, Gonzalez M, Ferrari M, Portugués A, Calvo MJ. ‘Efficacy of senna versus lactulose in terminal cancer patients treated with opioids’, J Pain Symptom Manage. 1998;15(1):1–7.

Ahmedzai SH (2015)
Ahmedzai SH, Leppert W, Janecki M, Pakosz A, Lomax M, Duerr H, et al. Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to-severe chronic cancer pain. Support Care Cancer. 2015;23(3):823–30.

Ahmedzai SH (2012)
Ahmedzai SH, Nauck F, Bar-Sela G, Bosse B, Leyendecker P, Hopp M. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain. Palliative Med. 2012;26(1):50–60.

Akihiro Tokoro (2019)
Akihiro Tokoro, Hisao Imai , Soichi Fumita, Toshiyuki Harada, Toshio Noriyuki, Makio Gamoh, Yusaku Akashi, Hiroki Sato, Yoshiyuki Kizawa. Incidence of opioid-induced constipation in Japanese patients with cancer pain: A prospective observational cohort study. Cancer Med 2019 Aug;8(10):4883-4891.

ALMouaalamy N (2021)
ALMouaalamy N. Opioid-Induced Constipation in Advanced Cancer Patients. Cureus. 2021;13(4):e14386.

Argoff CE (2015)
Argoff CE, Brennan MJ, Camilleri M, Davies A, Fudin J, Galluzzi KE, Gudin J, Lembo A, Stanos SP, Webster LR. Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation. Pain Med. 2015 Dec;16(12):2324-37 

Attar A (1999)
Attar A, Lémann M, Ferguson A, Halphen M, Boutron MC, Flourié B, Alix E, Salmeron M, Guillemot F, Chaussade S, Ménard AM, Moreau J, Naudin G, Barthet M. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut. 1999 Feb;44(2):226-30.

Baan van der FH (2020)
Baan van der FH, Koldenhof JJ, de Nijs EJ, Echteld MA, Zweers D, Hesselmann GM, et al. Validation of the Dutch version of the Edmonton Symptom Assessment System. Cancer Med. 2020;9(17):6111-21.

Bharucha AE (2020)
Bharucha AE, Lacy BE. Mechanisms, Evaluation, and Management of Chronic Constipation. Gastroenterology. 2020;158:1232–1249.

Birimoglu Okuyan C (2019)
Birimoglu Okuyan C, Bilgili N. Effect of abdominal massage on constipation and quality of life in older adults: A randomized controlled trial. Complement Ther Med. 2019 Dec;47:102219.

Boilesen SN (2017)
Boilesen SN, Tahan S, Dias FC, Melli LCFL, de Morais MB. Water and fluid intake in the prevention and treatment of functional constipation in children and adolescents: is there evidence? J Pediatr (Rio J). 2017;93:(4):320-327.

Bouhnik Y (2004)
Bouhnik Y, Neut C, Raskine L, Michel C, Riottot M, Andrieux C, Guillemot F, et al. Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation. Alimentary Pharmacology and Therapeutics. 2004;19(8):889-899.

Brenner DM (2020)
Brenner DM, Argoff CE, Fox SM, Bochenek W, D'Astoli P, Blakesley RE, Reasner DS, O'Dea CR, Cash BD. Efficacy and safety of linaclotide for opioid-induced constipation in patients with chronic noncancer pain syndromes from a phase 2 randomized study. Pain. 2020 May;161(5):1027-1036.

Bull J (2005)
Bull J, Wellman CV, Israel RJ, Barrett AC, Paterson C, Forbes WP. Fixed-Dose Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: Results of a Randomized, Placebo-Controlled Study and Open-Label Extension. J Palliat Med. 2005.105;18(7):593-600.

Candy B (2015)
Candy B, Jones L, Larkin PJ, Vickerstaff V, Tookman A, Stone P. Laxatives for the management of constipation in people receiving palliative care. Cochrane Database Syst. Rev. 2015;5:CD003448.

Candy B (2018)
Candy B, Jones L, Vickerstaff V, Larkin PJ, Stone P. Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care. Cochrane Database Syst Rev. 2018;6(6):CD006332.

Candy DC (2006)
Candy DC, Edwards D, Geraint M. Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy. J Pediatr Gastroenterol Nutr. 2006 Jul;43(1):65-70.

Caraceni A (2012)
Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13:e58–68.

Chassagne P (2017)
Chassagne P, Ducrotte P, Garnier P, Mathiex-Fortunet H. Tolerance and long-term efficacy of polyethylene glycol 4000 (Forlax®) compared to lactulose in elderly patients with chronic constipation. Journal of Nutrition, Health and Aging. 2017;21(4):429–439.

Chen CC (2005)
Chen CC, Su MY, Tung SY, Chang FY, Wong JM, Geraint M. Evaluation of polyethylene glycol plus electrolytes in the treatment of severe constipation and faecal impaction in adults. Curr Med Res Opin. 2005 Oct;21(10):1595-602.

Chey WD (2014)
Chey WD, Webster L, Sostek M, Lappalainen J, Barker PN, Tack J. Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med. 2014;370(25):2387-96.

Clark AJ (2004)
Clark AJ, Ahmedzai SH, Allan LG, Camacho F, Horbay GL, Richarz U, Simpson K. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain. Curr Med Res Opin. 2004 Sep;20(9):1419-28.

Clark K (2012)
Clark K, Smith JM, Currow DC. The prevalence of bowel problems reported in a palliative care population. J Pain Symptom Manage [Internet]. 2012;43(6):993–1000.

Clark K (2013)
Clark K, Currow DC. Constipation in palliative care: What do we use as definitions and outcome measures? J Pain Symptom Manage. 2013;45(4):753–62.

Clark K (2016)
Clark K, Lam LT, Talley NJ, Quinn J, Blight A, Byfieldt N, et al. Assessing the Presence and Severity of Constipation with Plain Radiographs in Constipated Palliative Care Patients. J Palliat Med. 2016;19(6):617–21.

Cobo Dols M (2021)
Cobo Dols M, Beato Zambrano C, Cabezón-Gutiérrez L, et al.: One-year efficacy and safety of naloxegol on symptoms and quality of life related to opioid-induced constipation in patients with cancer: KYONAL study. BMJ Support Palliat Care. 2021

Coffin B (2011)
Coffin B, Caussé C. Constipation assessment scales in adults: A literature review including the new Bowel Function Index. Expert Rev Gastroenterol Hepatol. 2011;5(5):601-13.

Cowlam S (2008)
Cowlam S, Vinayagam R, Khan U, Marsden S, Minty I, Moncur P, Bain I, Yiannakou YJ. Blinded comparison of faecal loading on plain radiography versus radio-opaque marker transit studies in the assessment of constipation. Clin Radiol. 2008 Dec;63(12):1326-31.

Dale O (2011)
Dale O, Moksnes K, Kaasa S. European Palliative Care Research Collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review. Palliat Med. 2011 Jul;25(5):494-503.

Davies A (2020)
Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, Emmanuel A. MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer. 2020 Jan;28(1):23-33.

De Giorgio R (2021)
De Giorgio R, Zucco FM, Chiarioni G, Mercadante S, Corazziari ES, Caraceni A, Odetti P, Giusti R, Marinangeli F, Pinto C. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel. Adv Ther. 2021 Jul;38(7):3589-3621. 

Dehghan M (2018)
Dehghan M, Fatehi Poor A, Mehdipoor R, Ahmadinejad M. Does abdominal massage improve gastrointestinal functions of intensive care patients with an endotracheal tube?: A randomized clinical trial. Complement Ther Clin Pract. 2018 Feb;30:122-128.

Dhingra L (2013)
Dhingra L, Shuk E, Grossman B, Strada A, Wald E, Portenoy A, et al. A qualitative study to explore psychological distress and illness burden associated with opioid-induced constipation in cancer patients with advanced disease. Palliat Med. 2013;27(5):447–56.

Drenthen AJM (2004)
Drenthen AJM, Everdingen van JJE, Vervest HAM (2004). Patiëntenvoorlichting in Aansluiting op Richtlijnontwikkeling. Evidence-based richtlijnontwikkeling. 2004;24:289-301.

Ducrotté P (2012)
Ducrotté P, Caussé C. The bowel function index: A new validated scale for assessing opioid-induced constipation. Curr Med Res Opin. 2012;28(3):457-66.

Dupoiron (2017)
Dupoiron, D, Stachowiak A, Loewenstein O, Ellery A, Kremers W, Bosse B, et al. A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PR. Eur J Pain. 2017;21(9):1528-1537.

Dupont C (2005)
C Dupont, B Leluyer, N Maamri, A Morali, J-P Joye, J-M Fiorini, A Abdelatif, C Baranes, S Benoit, A Benssoussan, J Boussioux, P Boyer, E Brunet, J Delorme, S Francois-Cecchin, F Gottrand, M Grassart, S Hadji, A Kalidjian, J Languepin, C Leissler, D Lejay, D Livon, J Lopez, J Mougenot, J Risse, C Rizk, D Roumaneix, J Schirrer, B Thoron, N Kalach. Double-Blind Randomized Evaluation of Clinical and Biological Tolerance of Polyethylene Glycol 4000 Versus Lactulose in Constipated Children. Journal of Pediatric Gastroenterology and Nutrition November 2005;41:625-633.

Farmer AD (2018)
Farmer AD, Holt CB, Downes TJ, Ruggeri E, Del Vecchio S, De Giorgio R. Pathophysiology, diagnosis, and management of opioid-induced constipation. Lancet Gastroenterol Hepatol. 2018;3(3):203–12.

Fasano A (2015)
Fasano A, Visanji NP, Liu LWC, Lang AE, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. (2015) 14:625–39.

Ferguson D (2021)
Ferguson D, Holmes RD, Scott R, Alsahafi M, Buckley J, Donnellan F, Prichard DO. Colonic stool burden on computed tomography does not correlate with bowel habit: a cross-sectional study. Abdom Radiol (NY). 2021 Feb;46(2):506-516.

Ford AC (2013)
Ford AC, Brenner DM, Schoenfeld PS. Efficacy of pharmacological therapies for the treatment of opioid?induced constipation: systematic review and meta?analysis. Am J Gastroenterol. 2013;108(10):1566?1574.

Freedman MD (1997)
Freedman MD, Schwartz HJ, Roby R, Fleisher S. Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial. Journal of Clinical Pharmacology. 1997;37(10):904–907.

Goldner W (2016)
Goldner W. Cancer-Related Hypercalcemia. J Oncol Pract. 2016;12(5):426-32.

Groot de JWB (2010)
Groot de JWB, Peters FTM, Reyners AKL. Behandeling van obstipatie in de palliatieve fase. Ned Tijdschr Geneeskd. 2010;154(49):2277–82.1

Hammer B (1992)
Hammer B, Ravelli GP. Chronic functional constipation lactitol maintenance dose, a multicentre comparative study with lactulose. Ther Schweiz 1992;8:328–335. [In German]

Hasson F (2020)
Hasson F, Muldrew D, Carduff E, Finucane A, Graham-Wisener L, Larkin P, et al. ‘Take more laxatives was their answer to everything’: A qualitative exploration of the patient, carer and healthcare professional experience of constipation in specialist palliative care. Palliat Med. 2020;34(8):1057–66.

Heitland W (1988)
Heitland W, Mauersberger H. Study of the laxative effect of lactitol as opposed to lactulose in an open, randomized comparative study. Schweiz Rundsch Med Prax 1988;77:493–495. [In German]

Huang TT (2015)
Huang TT, Yang SD, Tsai YH, Chin YF, Wang BH, Tsay PK. Effectiveness of individualised intervention on older residents with constipation in nursing home: a randomised controlled trial. Journal of Clinical Nursing. 2015;23-24;3449–3458.

Hussain ZH (2014)
Hussain ZH, Whitehead DA, Lacy BE. Fecal impaction. Curr Gastroenterol Rep. 2014 Sep;16(9):404.

IKNL (2010)
IKNL. Richtlijn ’Hypercalciemie’. 2010. Available at:

IKNL (2018)
IKNL. Richtlijn ’Ileus’. 2018. Available at:

IKNL (2019)
IKNL. Richtlijn ’Pijn bij patiënten met gevorderde stadia van COPD en hartfalen’. 2019. Available at:

IKNL (2019)
IKNL. Richtlijn ’Pijn bij patiënten met kanker’. 2019. Available at:

IKNL/Palliactief (2017)
IKNL/Palliactief. Kwaliteitskader palliatieve zorg Nederland. 2017;1-70.

Ishihara M (2012)
Ishihara M, Ikesue H, Matsunaga H, Suemaru K, Kitaichi K, Suetsugu K, Oishi R, Sendo T, Araki H, Itoh Y; Japanese Study Group for the Relief of Opioid-induced Gastrointestinal Dysfunction. A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction. Clin J Pain. 2012 Jun;28(5):373-81.

Janssen DJA (2008)
Janssen DJA, Spruit MA, Wouters EFM, Schols JMGA. Dailty symptom burden in end-stage chronic organ failure: a systematic review. Palliat Med 2008

Johanson JF (2007)
Johanson JF, Kralstein J. Chronic constipation: a survey of the patient perspective.Aliment Pharmacol Ther. 2007;25(5):599-608.

K Clark (2012)
K Clark, A Hipwell, N Byfieldt; A retrospective pilot study to explore the timing of cessation of laxatives before death in a palliative care unit. 2012 International Journal of Palliative Nursing 2012, Vol 18, No 7.

Kamm MA (2011)
Kamm MA, Mueller-Lissner S, Wald A, Richter E, Swallow R, Gessner U. Oral Bisacodyl Is effective and well-tolerated in patients with chronic constipation. Clin Gastroenterol Hepatol. 2011;9(7):577-83.

Katakami N (2017)
Katakami N, Oda K, Tauchi K, Nakata N, Shinozaki K, Yokota T, et al. Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Cancer. J Clin Oncol. 2017;35(17):1921-1928.

Katelaris P (2016)
Katelaris P, Naganathan V, Liu K, Krassas G, Gullotta J. Comparison of the effectiveness of polyethylene glycol with and without electrolytes in constipation: a systematic review and network meta-analysis. BMC Gastroenterol. 2016 Mar 31;16:42.

Kumar L (2014)
Kumar L, Barker C, Emmanuel A. Opioid-induced constipation: pathophysiology, clinical consequences, and management. Gastroenterol Res Pract. 2014;2014: 141737.

Lacy BE (2016)
Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393-1407.

Lämås K (2009)
Lämås K, Lindholm L, Stenlund H, Engstrom B, Jacobsson C. Effects of abdominal massage in management of constipation: a randomized controlled trial. International Journal of Nursing Studies. 2009;46 (6);759–767.

Landelijke eerstelijns samenwerkingsafspraak palliatieve zorg
Landelijke eerstelijns samenwerkingsafspraak palliatieve zorg. Te vinden op:

Larkin PJ (2008)
Larkin PJ, Sykes NP, Centeno C, Ellershaw JE, Elsner F, Eugene B, Gootjes JR, Nabal M, Noguera A, Ripamonti C, Zucco F, Zuurmond WW; European Consensus Group on Constipation in Palliative Care. The management of constipation in palliative care: clinical practice recommendations. Palliat Med. 2008 Oct;22(7):796-807.

Larkin PJ (2018)
Larkin PJ, Cherny NI, La Carpia D, Guglielmo M, Ostgathe C, Scotté F, Ripamonti CI. ESMO Guidelines Committee. Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018;29(4):IV111-IV125.

Lee-Robichaud H (2010)
Lee-Robichaud H, Thomas K, Morgan J, Nelson RL. Lactulose versus Polyethylene Glycol for Chronic Constipation. Cochrane Database Syst Rev. 2010;(7):CD007570.

Lewis SJ (1997)
Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920-4.

Librach SL (2010)
Librach SL, Bouvette M, De Angelis C, Farley J, Oneschuk D, Pereira JL, Syme A; Canadian Consensus Development Group for Constipation in Patients with Advanced Progressive Illness. Consensus recommendations for the management of constipation in patients with advanced, progressive illness. J Pain Symptom Manage. 2010 Nov;40(5):761-73.

LoCasale RJ (2016)
LoCasale RJ, Datto C, Wilson H, et al. The burden of opioid-induced constipation: discordance between patient and health care provider reports. J Manag Care Spec Pharm. 2016;22(3):236–45.

Marquis P (2005)
Marquis P, De La Loge C, Dubois D, McDermott A, Chassany O. Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire. Scand J Gastroenterol. 2005;40(5):540-51.

McMillan SC (1989)
McMillan SC, Williams FA. Validity and reliability of the Constipation Assessment Scale. 1989;12(3):183-8.

McRae MP (2020)
McRae MP. Effectiveness of Fiber Supplementation for Constipation, Weight Loss, and Supporting Gastrointestinal Function: A Narrative Review of Meta-Analyses. J Chiropr Med. 2020;19(1): 558-64. 

Mercadante S (2018)
Mercadante S, Masedu F, Maltoni M, De Giovanni D, Montanari L, Pittureri C, et al. The prevalence of constipation at admission and after 1 week of palliative care: a multi-center study. Curr Med Res Opin. 2018;34(7):1187–92.

Mínguez M (2016)
Mínguez M, López Higueras A, Júdez J. Use of polyethylene glycol in functional constipation and fecal impaction. Rev Esp Enferm Dig. 2016 Dec;108(12):790-806.

Moll van Charante EP (2011)
Moll van Charante EP, Jongh de TOH. Auscultatie van de buik. Ned Tijdschr Geneeskd. 2011;155:A2657.

Mori H (2019)
Mori H, Suzuki H, Hirai Y, Okuzawa A, Kayashima A, Kubosawa Y, Kinoshita S, Fujimoto A, Nakazato Y, Nishizawa T, Kikuchi M. Clinical features of hypermagnesemia in patients with functional constipation taking daily magnesium oxide. J Clin Biochem Nutr. 2019 Jul;65(1):76-81.

McClurg D (2016)
McClurg D, Hagen S, Jamieson K, Dickinson L, Paul L, Cunnington A. Abdominal massage for the alleviation of symptoms of constipation in people with Parkinson's: a randomised controlled pilot study. Age Ageing. 2016 Mar;45(2):299-303. 

Morishita D (2021)
Morishita D, Tomita T, Mori S, Kimura T, Oshima T, Fukui H, Miwa H. Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial. Am J Gastroenterol. 2021 Jan 1;116(1):152-161. 

Mueller-Lissner SA (2010)
Mueller-Lissner SA. Wald A. Constipation in adults. BMJ clinical evidence. 2010;2010:0413.

Nagaviroj K (2011)
Nagaviroj K, Yong WC, Fassbender K, Zhu G, Oneschuk D. Comparison of the constipation assessment scale and plain abdominal radiography in the assessment of constipation in advanced cancer patients. J Pain Symptom Manage. 2011;42(2):222–8.

Neefjes ECW (2014)
Neefjes ECW, Vorst van der MJDL, Boddaerts MSA, Zuurmond WWA, Vliet van der HJ, Beeker A, et al. Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone. BMC Palliat Care. 2014;13(1):1-7.

Oosten AW (2015)
Oosten AW, Oldenmenger WH, Mathijssen RHJ, Van Der Rijt CCD. A Systematic Review of Prospective Studies Reporting Adverse Events of Commonly Used Opioids for Cancer-Related Pain: A Call for the Use of Standardized Outcome Measures. J Pain. 2015;16(10):935–46.

Pannemans J (2020)
Pannemans J, Masuy I, Tack J. Functional Constipation: Individualising Assessment and Treatment. Drugs. 2020;80(10):947–963.

Peate I (2016)
Peate I. How to perform digital removal of faeces. Nurs Stand. 2016 Jun 1;30(40):36-9.

Piche T (2020)
Piche T, Dapoigny M. Comparative efficacy and safety of lactulose plus paraffin vs polyethylene glycol in functional constipation: a randomised clinical study. United European Gastroenterol J. 2020 Oct;8(8):923-932

Portenoy RK (2008)
Portenoy RK, Thomas J, Moehl Boatwright ML, Tran D, Galasso FL, Stambler N, Von Gunten CF, Israel RJ. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study. J Pain Symptom Manage. 2008;35(5):458-68. 

Prichard DO (2018)
Prichard DO, Bharucha AE. Recent advances in understanding and managing chronic constipation. F1000Res. 2018 Oct 15;7:F1000 Faculty Rev-1640. doi: 10.12688/f1000research.15900.1. PMID: 30364088; PMCID: PMC6192438.

Ramesh PR (1998)
Ramesh PR, Kumar KS, Rajagopal MR Blachandran P, Warrier PK. Managing morphine-induced constipation: a controlled comparison of an Ayurvedic formulation and senna. J Pain Symptom Manage. 1998;16(4):240–244.

Rao SSC (2005)
Rao SSC, Ozturk R, Laine L. Clinical utility of diagnostic tests for constipation in adults: a systematic review. Am J Gastroenterol. 2005;100(7):1605–15.

Rentz AM (2009)
Rentz AM, Yu R, Müller-Lissner S, Leyendecker P. Validation of the Bowel Function index to detect clinically meaningful changes in opiod-induced constipation. J Med Econ. 2009;12(4):371-83.

Rentz AM (2011)
Rentz AM, Hanswijck de Jonge van P, Leyendecker P, Hopp M. Observational, nonintervention, multicenter study for validation of the Bowel Function Index for constipation in European countries. Curr Med Res Opin. 2011;27(1):35-44.

Rietjens JA (2008)
Rietjens JA, Zuylen van L, Veluw van H, Wijk van der L, MSc, Heide van der A, Rijt van der CC. Palliative Sedation in a specialized unit for acute palliative care in a cancer hospital: comparing patients dying with and without. J Pain Symptom Manage 2008;36(3):228-234

Riley JP (2017)
Riley JP, Beattie JM. Palliative care in heart failure: facts and numbers. ESC Hear Fail. 2017;4(2):81–7.

Rumman A (2016)
Rumman A, Gallinger ZR, Liu LWC. Opioid induced constipation in cancer patients: pathophysiology, diagnosis and treatment. Expert Review of Quality of Life in Cancer Care. 2016;1(1):25-35.

Saad RJ (2010)
Saad RJ, Rao SSC, Koch KL, Kuo B, Parkman HP, McCallum RW, et al. Do stool form and frequency correlate with whole-gut and colonic transit results from a multicenter study in constipated individuals and healthy controls. Am J Gastroenterol. 2010;105(2):403-11.

Sarrió RG (2021)
Sarrió RG, Calsina-Berna A, García AG, Esparza-Miñana JM, Ferrer EF, Working Group ActEIO Project, Porta-Sales J. Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients. BMC Palliat Care. 2021;20(1):1.

Schipper HG (2001)
Schipper HG, Godfried MH. Fysische diagnostiek – ascites. Ned Tijdschr Geneeskd. 2001;145(6):260-4.

Schryver de AM (2005)
Schryver de AM, Keulemans YC, Peters HP, Akkermans LM, Smout AJ, Vries de WR, Berge van-Henegouwen GP. Effects of regular physical activity on defecation pattern in middle-aged patients complaining of chronic constipation. Scand J Gastroenterol. 2005; 40(4),422-429

Serra J (2020)
Serra J, Pohl D, Azpiroz F, Chiarioni G, Ducrotté P, Gourcerol G, Hungin APS, Layer P, Mendive JM, Pfeifer J, Rogler G, Scott SM, Simrén M, Whorwell P. The Functional Constipation Guidelines Working Group. European society of neurogastroenterology and motility guidelines on functional constipation in adults. Neurogastroenterol Motil. 2020;32(2):e13762.

Slappendel R (2006)
Slappendel R, Simpson K, Dubois D, Keininger DL. Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain. Eur J Pain. 2006;10(3):209.

Slatkin N (2009)
Slatkin N, Thomas J, Lipman AG, Wilson G, Boatwright ML, et al. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients. J Support Oncol. 2009;7(1):39-46.

Sobrado WC (2018)
Sobrado WC, Neto IJFC, Pinto RA, Sobrado LF, Nahas SC, Cecconello I. Diagnosis and treatment of constipation: a clinical update based on the Rome IV criteria. Coloproctol. 2018;38(2):137-144

Solano JP (2006)
Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006;31(1):58–69.

Sridharan K (2018)
Sridharan K, Sivaramakrishnan G. Drugs for Treating Opioid-Induced Constipation: A Mixed Treatment Comparison Network Meta-analysis of Randomized Controlled Clinical Trials. J Pain Symptom Manage. 2018;55(2):468-479.e1.

Suares NC (2011)
Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106(9):1582–91.

Sykes N (1991a)
Sykes, N. A clinical comparison of laxatives in a hospice. Palliat Med. 1991b;5(4):307–14.

Sykes N (1991b)
Sykes N. A clinical comparison of lactulose and senna with magnesium hydroxide and liquid paraffin emulsion in a palliative care population. Unpublished data, 1991a. Central. 2017(8).

Sykes (1996)
Sykes, N. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer. Palliative Med. 1996;10(2):135-144. 

Tarumi Y (2013)
Tarumi Y, Wilson MP, Szafran O, Spooner GR. Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients. J Pain Symptom Manage. 2013 Jan;45(1):2-13.

Teunissen SCCM (2007)
Teunissen SCCM, Wesker W, Kruitwagen C, Haes de HCJM, Voest EE, Graeff de A. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage.2007;34(1):94-104. 

Thomas J (2008)
Thomas J, Karver S, Cooney A, Chamberlain BH, Watt CK, et al. Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med. 2008;58(22):2332-43.

Turan N (2016)
Turan N, A?t TA. The Effect of Abdominal Massage on Constipation and Quality of Life. Gastroenterol Nurs. 2016 Jan-Feb;39(1):48-59.

Verkissen MN (2019)
Verkissen MN, Hjermstad MJ, Belle van S, Kaasa S, Deliens L, Pardon K. Quality of life and symptom intensity over time in people with cancer receiving palliative care: Results from the international European Palliative Care Cancer Symptom study. PLoS One. 2019;14(10):1–16.

Voskuijl W (2004)
W Voskuijl, F de Lorijn, W Verwijs, P Hogeman, J Heijmans, W Makel, J Taminiau, M Benninga. PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. Gut 2004;53:1590-1594.

Wang BX (2007)
Wang BX, Wang MG, Jiang MZ, et al. Forlax in the treatment of childhood constipation: a randomised, controlled, multicenter clinical study. Zhongguo Dang Dai Er Ke Za Zhi 2007;9(5):429-32.

Webster L (2013)
Webster L, Dhar S, Eldon M, Masuoka L, Lappalainen J, Sostek M. A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation. Pain. 2013;154:1 542–1550.

Yildirim D (2019)
Yildirim D, Can G, Köknel Talu G. The efficacy of abdominal massage in managing opioid-induced constipation. Eur J Oncol Nurs. 2019 Aug;41:110-119.Zagzag J (2018)
Zagzag J, Hu MI, Fisher SB, Perrier ND. Hypercalcemia and cancer: Differential diagnosis and treatment. CA Cancer J Clin. 2018;68(5):377-386.

Zhang C (2003)
C Zhang, G Zhang, K Zhang, Y Fu. Clinical Evaluation of Polyethylene Glycol 4000 in Treatment of Functional Constipation in Elderly Patients. World Chinese Journal of Digestology 2003;11(9):1399-401.